India allows limited exports of anti-malaria drug after Trump warns of retaliation
India, the world's main supplier of generic drugs, said on Tuesday it will allow limited exports of the anti-malaria drug hydroxychloroquine that U.S. President Donald Trump has touted as a potential weapon in the fight against the coronavirus.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: American Health | Coronavirus | COVID-19 | Health | Hydroxychloroquine | India Health | Malaria | Trump | USA Health